Condition: Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Sponsor: BeOne Medicines
The goal of this study is to compare how well sonrotoclax plus obinutuzumab works versus venetoclax plus rituximab in treating adults with relapsed and/or refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). The study will also compare how well sonrotoclax plus rituximab works versus venetoclax plus rituxumab in treating adults with R/R CLL/SLL. The safety of these treatments will also be assessed.
This description comes directly from the study's public registry record.
Study Director · 1-877-828-5568 · clinicaltrials@beonemed.com
Always discuss trial participation with your own doctor first.
| Uci Health Laguna Hills | Laguna Hills, California, United States | Recruiting |
| Chao Family Comprehensive Cancer Center | Orange, California, United States | Recruiting |
| Stanford Cancer Institute | Palo Alto, California, United States | Recruiting |
| Scripps Prebys Cancer Center | San Diego, California, United States | Recruiting |
| Rocky Mountain Cancer Centers (Williams) Usor | Aurora, Colorado, United States | Recruiting |
| Yale University Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Eastern Connecticut Hematology and Oncology | Norwich, Connecticut, United States | Recruiting |
| Cleveland Clinic Florida | Weston, Florida, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Illinois Cancer Specialists (Niles) Usor | Niles, Illinois, United States | Recruiting |
| University of Louisville, Brown Cancer Center | Louisville, Kentucky, United States | Recruiting |
| Mary Bird Perkins Cancer Center | Baton Rouge, Louisiana, United States | Recruiting |
+ 175 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06943872